Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline for panitumumab-induced skin toxicity in metastatic colorectal cancer
2010-019564-37Phase 2Terminated
- Sponsor
- GMIHO
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cutaneous reaction and colorectal cancer (CRC) comparing Basic skin treatment + doxycycline with Basic skin treatment + placebo (2 arms). Primary endpoint: Time until unblinding of skin therapy allocation due to insufficient efficacy. Started Jan 2011; status: terminated.
02
Drugs
doxycycline
03
Conditions
cutaneous reactioncolorectal cancer (CRC)
Beyond the preview
Go deeper on 2010-019564-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019564-37.